Pulsenmore Ltd. (PLSM) AI Stock Analysis

Pulsenmore Ltd., a medical device company incorporated in 2014 and based in Omer, Israel, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides its Pulsenmore ES and Pulsenmore FC products across several international markets, including the United States, the United Kingdom, Northern Ireland, and Europe. Operating with 71 employees following its 2026 IPO on the NASDAQ, Pulsenmore focuses on commercializing portable ultrasound technology.

Pulsenmore demonstrated significant top-line expansion, growing revenue from $1.6M in FY2021 to $10.6M in FY2022, before dropping 42.1% to $6.1M in FY2023. Revenue recovered to $9.6M in FY2024 and expanded 315.2% to $40.0M in FY2025, reflecting a 4-year revenue CAGR of 124.5%. Gross margin widened considerably to 84.2% in FY2025 compared to 0.6% in FY2023 and 21.4% in FY2024. While operating margin improved from -1390.2% in FY2021 to -30.4% in FY2025, net income remained negative at -$15.9M. For the latest quarter ended June 30, 2026, quarterly revenue growth was 52.0% year-over-year, alongside a TTM profit margin of -66.0% and TTM EPS of -$1.33.

As of June 30, 2026, Pulsenmore held $70.3M in cash and short-term investments against total debt of $34.6M, resulting in net cash of $35.7M. The company reported total assets of $100.6M and shareholders' equity of $48.7M, supporting a current ratio of 1.84 and a debt-to-equity ratio of 0.71. In FY2025, operating cash flow stood at -$32.9M and free cash flow was -$33.0M, while capital expenditures were $135,000. Over five years, the share count increased by 12.4%.

Pulsenmore trades at a price-to-sales multiple of 1.1x, which sits below the 4.1x median of its US-listed Healthcare peers. Its enterprise value stands at -$7.1M with an EV-to-revenue multiple of 0.1x and a price-to-book ratio of 1.0x. The company's market cap is $12.2M, with a stock price of $1.87 as of October 16, 2026, well below its 52-week high of $12.97 and near its 52-week low of $1.71. Meanwhile, the S&P 500 (SPY) delivered a 1-year return of 16.8% and a 5-year return of 83.0%.

There are no consensus analyst ratings, mean price targets, or earnings estimates published for Pulsenmore. The stock recorded a last close of $1.87 on October 16, 2026, having traded between a 52-week low of $1.71 and a 52-week high of $12.97. With an IPO year of 2026 and trailing twelve-month EPS of -$1.33 through the quarter ended June 30, 2026, the company operates without formal analyst coverage or scheduled next earnings announcement dates in available tracking records.

This page is an AI-written research summary of Pulsenmore Ltd. (PLSM). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: PLSM income statement, PLSM balance sheet, PLSM key metrics, PLSM chart. See the PLSM stock overview for the latest quote and news.